Question 1

What FDA regulations govern medical device packaging?

Accepted Answer

21 CFR Part 801 covers labeling requirements for medical devices. 21 CFR Part 820 (Quality System Regulation) covers packaging processes as part of device manufacturing. ISO 11607 specifies requirements for sterile medical device packaging performance and validation. ISO 15223-1 covers symbols used on medical device labels. For Class II and Class III devices, packaging specifications may be part of the premarket submission. This is a regulatory specialization — engaging an FDA regulatory consultant for device packaging is strongly recommended.

Question 2

What information is required on medical device packaging labels?

Accepted Answer

Required elements include: device identification and model number, manufacturer name and address (or authorized representative for imported devices), instructions for use reference (or complete IFU for simple devices), sterilization method indicator, expiration date (for sterile products), lot or batch number for traceability, and applicable FDA classification information. Symbols must meet ISO 15223-1 standards. All text must be in English for US distribution; multilingual labeling is required for international markets.

Question 3

How do sterile medical device packages maintain sterility during storage and distribution?

Accepted Answer

Sterile barrier systems — typically Tyvek/film pouches, rigid formed trays with film lids, or header bags — maintain device sterility from manufacturing through point of use. The barrier material is selected to permit sterilization (ETO, gamma, steam depending on device compatibility) while maintaining microbial barrier properties through shelf life. Packaging validation per ISO 11607 Part 2 demonstrates that the system maintains sterility under the specified distribution and storage conditions.

Question 4

What packaging formats are most common for Class I and Class II medical devices?

Accepted Answer

Class I devices (low risk): standard folding carton with device IFU included, or Tyvek/film pouch if sterile. Class II devices (moderate risk): formed tray with film lid (for sterile devices), or custom folding carton with device-specific insert and complete labeling. Combination products (device and drug component): regulated under the most restrictive applicable pathway, typically FDA's Office of Combination Products determination.

Question 5

How do medical device companies ensure packaging integrity throughout the supply chain?

Accepted Answer

Distribution simulation testing per ASTM D4169 or ISTA protocols validates packaging performance through the expected distribution environment. For sterile devices, package integrity testing (dye penetration, microbial challenge) verifies that sterile barrier properties are maintained after distribution conditions. Packaging validation generates the documented evidence that FDA expects to see in quality system records and, for some devices, in premarket submissions.

Question 6

Can medical device packaging include digital traceability features?

Accepted Answer

Yes — and for many device categories, traceability is a regulatory requirement. UDI (Unique Device Identification) under FDA 21 CFR Part 830 requires specific UDI data on device labels, either as human-readable text plus a barcode (linear or 2D/DataMatrix) or an RFID tag. The UDI must be present on both the device and the device labeling. Serialized UDI enables supply chain traceability and enables device recall management.

Question 7

What sustainability considerations apply to medical device packaging?

Accepted Answer

Medical device packaging sustainability faces a fundamental tension with regulatory requirements — sterile barrier systems that maintain required performance are not always recyclable or compostable under standard consumer infrastructure. ISO 11607 compliance takes precedence over sustainability preferences for sterile device packaging. That said, secondary packaging (cartons, labels, inserts) can use sustainable materials, and some medical device companies are actively developing recyclable sterile barrier systems within the regulatory framework.

Question 8

How should a medical device startup approach packaging for an early commercial launch?

Accepted Answer

Engage a regulatory consultant early — packaging decisions made without regulatory guidance often require costly revisions before FDA submission or clearance. Initial packaging for de novo or 510(k) submissions must match what will be commercially used. At PackTist, we work with device companies from specification through production, and our team can coordinate with your regulatory team to ensure packaging specifications align with submission requirements.

Medical Device Packaging.

Your custom box, quoted.

The full specification book.

Medical Device Packaging

Every detail. Intentional.

The sterile barrier system

ISO 11607 in two parts

Evidence, not assertion

Tyvek admits sterilant

Chevron peel presentation

Change control applies

Built like architecture.

Every surface, hand-selected.

Material

Finishes

Add-ons

The full kit of capabilities.

Sizing & dieline.

Pricing & minimums.

What brands say.

Questions, answered.

Other products you might love.

Ready to start your Medical Device Packaging project?